The first medical device to treat childhood attention deficit hyperactivity disorder, or ADHD, was OK'd Friday by the US Food and Drug Administration. The device delivers a low-level electrical pulse to the parts of the brain.
The first medical device to treat childhood attention deficit hyperactivity disorder, or ADHD, was OK'd Friday by the US Food and Drug Administration. Designated for children ages 7 to 12 who are not currently on medication for the disorder, the device delivers a low-level electrical pulse to the parts of the brain responsible for ADHD symptoms.
Young people on amphetamines for ADHD have twice the psychosis risk compared to other stimulants, study says"This new device offers a safe, non-drug option for treatment of ADHD in pediatric patients through the use of mild nerve stimulation, a first of its kind," Carlos Peña, director of the Division of Neurological and Physical Medicine Devices in the FDA's Center for Devices and Radiological Health, said in a statement.
ADHD is among the most common neurodevelopmental disorders of childhood. According to the US Centers for Disease Control and Prevention, children with ADHD might have trouble paying attention, controlling impulsive behaviors or be overly active. Doctors typically recommend a few treatment options for children: medication, behavior modification or both.
The device was previously approved for the treatment of epilepsy and depression in Europe and Canada. Studies at UCLA found the stimulation decreased seizure activity by inhibiting overactive neurons in one section of the brain, while stimulating blood flow in the areas that control mood, attention and executive function.The device has also been investigated as a possible treatment for traumatic brain injury in veterans.Michelle Watson contributed to this report.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
More screen time linked to higher risk of ADHD in preschool-aged children: StudyKids with more screen time by age 5 were 7.7 times more likely to have ADHD, according to a new study.
Read more »
FDA approves first generic naloxone nasal spray to treat opioid overdoseThe life-saving medication that can stop or reverse the effects of an opioid overdose may prevent thousands of deaths.
Read more »
More screen time linked to higher risk of ADHD in preschool-aged children: StudyA new study out of the University of Alberta has found that by the age of 5, children who spent two hours or more looking at a screen each day were 7.7 times more likely to meet the criteria for a diagnosis of attention deficit hyperactivity disorder (ADHD) when compared to children who spent 30 minutes
Read more »
FDA approves Teva's generic nasal spray to treat opioid overdoseGeneric drugmaker Teva Pharmaceutical Industries Ltd on Friday received approval...
Read more »
FDA bans sales of transvaginal mesh amid safety concernsThe FDA banned manufacturers of surgical mesh products from selling and distributing their products in the United States immediately. Each year thousands of women undergo transvaginal surgery mesh procedures.
Read more »
We Asked The FDA About 8 Popular Food Safety MythsFrom drinking old milk to storing butter at room temperature to double-dipping chips.
Read more »
FDA orders transvaginal surgical mesh pulled from marketThe U.S. Food and Drug Administration on Tuesday ordered makers of transvaginal ...
Read more »
FDA orders manufacturers to halt sales of surgical mesh used in certain pelvic operationsThe agency ordered the two remaining manufacturers of surgical mesh used for certain pelvic operations to stop selling the products immediately, citing the lack of a “reasonable assurance” of safety and effectiveness.
Read more »
FDA orders Boston Scientific, Coloplast to stop selling surgical meshThe Food and Drug Administration orders Boston Scientific and Coloplast to stop selling surgical mesh used for some pelvic operations.
Read more »
Frozen tuna recall linked to salmonella outbreak, FDA and CDC SaysThe CDC and FDA issued advisory notices to caution consumers about the reason for Jensen Tuna's voluntary recall.
Read more »
Dining room deregulation: Trump's FDA may soon drop rules for cherry pie, milk, French dressingThe requirements are seen as arcane by many and are a sore spot in the food industry, with companies saying they prevent innovation or prompt lawsuits.
Read more »